Nasadur 1 Mg/Ml (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasadur 1 mg/mL, is an alpha‑adrenergic agonist presented as a 1 mg/mL nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasadur 1 mg/mL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution. Clients benefit from reliable logistics, batch traceability and responsive technical support.

Xylometazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa, improving airflow.

- Common cold: alleviates nasal congestion by constricting dilated blood vessels in the nasal mucosa, providing rapid symptom relief. - Sinusitis: improves nasal patency and drainage by reducing mucosal edema, aiding recovery from sinus inflammation. - Allergic rhinitis: relieves congestion caused by allergic inflammation through localized vasoconstriction of nasal vessels.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Sneezing: transient increase in sneezing episodes. - Dryness: dryness of nasal mucosa. - Headache: mild headache. - Nasal bleeding: occasional mild epistaxis. - Taste disturbance: temporary alteration of taste perception.

Serious or Rare Side Effects: - Rebound congestion: prolonged use may lead to rhinitis medicamentosa. - Hypertension: systemic absorption can raise blood pressure in susceptible individuals. - Cardiac arrhythmia: rare cases of tachycardia reported. - Ischemic ocular events: rare visual disturbances. - Severe allergic reaction: anaphylaxis or angioedema in extremely sensitive patients.

When using Nasadur 1 mg/mL, consider the following precautions to ensure safe and effective treatment. - Age limitation: avoid use in children under 6 years unless directed by a physician. - Duration of use: limit treatment to no more than 3–5 consecutive days to prevent rebound congestion. - Cardiovascular disease: use cautiously in patients with hypertension or heart disease. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Drug interactions: inform provider of concurrent nasal or systemic decongestants. - Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with certain medications; awareness of these interactions helps minimize adverse effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase risk of hypertensive crisis. - Systemic sympathomimetics (e.g., pseudoephedrine): additive vasoconstrictive effects can raise blood pressure.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may reduce efficacy of blood pressure control. - Tricyclic antidepressants: potential for increased cardiovascular stimulation. - Beta‑blockers: may blunt compensatory heart‑rate response.